Atopic dermatitis (AD) is a chronic, non-infectious disease that most often begins in
childhood. It is characterized by itchy erythematous lesions located mainly on the
flexural surfaces, as well as dry skin and lichenification. The pathogenesis of atopic
dermatitis consists of immunological, genetic, and environmental aspects that start
the dysfunction of the epidermal barrier and promote dysregulation of the immune
response. This entire process leads to chronic inflammation, and it is related to
oxidative stress. Studies confirm that bioactive compounds, plant extracts, and
hydrogels have important antioxidant and anti-inflammatory properties. Moreover,
they are able to control reactive oxygen species (ROS) production due to antioxidant
therapies, which may become a promising strategy for treating AD. The
introduction of such therapeutic strategies could help improve the quality of life for
patients with atopic dermatitis and reduce the symptoms associated with this
chronic skin disease. This piece aims to explore the aspect of oxidative stress in the
pathogenesis of atopic dermatitis and to evaluate the efficacy of various antioxidant
therapies with a focus on their therapeutic potential.
Keywords: atopic dermatitis, oxidative stress, oxidative stress in atopic dermatitis,
ROS, reactive oxidative stress
